Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro

AIDS

Volumn 10, Issue 7, 1996, Pages

  Uittenbogaart, Christel H ^a,b   Anisman, Deborah J ^b   Jamieson, Beth D ^b   Kitchen, Scott ^b   Schmid, Ingrid ^a,b   Zack, Jerome A ^a,b   Hays, Esther F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; Immunodeficiency; Maturation; Thymus; Virus expression

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MEMBRANE ANTIGEN;

ANTIBODY TITER; ARTICLE; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLANT GROWTH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYMOCYTE; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS STRAIN;

EID: 0029954511     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199606001-00001     Document Type: Article

References (26)

1. Galy A, Verma S, Barcena A, Spits H: Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 1993, 178:391-401.
2. Rosenzweig M, Clark DP, Gaulton GN: Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 1993, 7:1601-1605.
3. Prevot S, Audouin J, Andre-Bougaran J, et al.: Thymic pseudotumorous enlargement due to follicular hyperplasia in a human immunodeficiency virus sero-positive patient. Am J Clin Pathol 1992, 97:420-425.
4. Calabro ML, Zanotto C, Calderazzo F, et al.: HIV-1 infection of the thymus: evidence for a cytopathic and thymotropic viral variant in vivo. AIDS Res Hum Retroviruses 1995, 11:11-19.
5. Valentin H, Nugeyre M-T, Vuillier F, et al.: Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol 1994, 68:3041-3050.
6. Stanley SK, McCune JM, Kaneshima H, et al.: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993, 178:1151-1163.
7. Jamieson BD, Aldrovandi GM, Planelles V, et al.: Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994, 68:3478-3485.
8. Su L, Kaneshima H, Bonyhadi M, et al.: HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 1995, 2:25-36.
9. Zack JA, Haislip AM, Krogstad P, Chen ISY: Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992, 66:1717-1725.
10. Hays EF, Uittenbogaart CH, Brewer J, Vollger LW, Zack JA: In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS 1992, 6:265-272.
11. Uittenbogaart CH, Anisman DJ, Zack JA, Economides A, Schmid I, Hays EF: Effects of cytokines on HIV-1 production by thymocytes. Thymus 1995, 23:155-175.
12. Uittenbogaart CH, Higashitani S, Schmid I, Vollger LW, Boone T, Clement LT: Interleukin-4 induces expression of the CD45RA antigen on human thymocyte subpopulations. Int Immunol 1990, 2:1179-1187.
13. Vollger LW, Uittenbogaart CH: Interleukin-7 promotes the generation of phenotypically mature CD45RA positive human thymocytes in vitro. Cytokine 1993, 5:157-168.
14. Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV: Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992, 13:204-208.
15. Schmid I, Uittenbogaart CH, Giorgi JV: A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 1991, 12:279-285.
16. Lehman EL: Nonparametrics. Oakland: Holden Day, Inc.; 1975.
17. Ueno Y, Hays E, Hultin L, Uittenbogaart CH: Human thymocytes do not respond to interleukin-2 after removal of mature 'bright' CD5 positive cells. Cell Immunol 1989, 124:239-251.
18. Blue M, Levine H, Daley JF, Branton KR, Schlossman SF: Expression of CD1 and class I MHC antigens by human thymocytes. J Immunol 1989, 142:2714-2720.
19. Jedder TF, Clement LC, Cooper MD: Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression. J Immunol 1985, 134:2983-2988.
20. Chassagne J, Verrelle P, Dionet C, et al.: A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol 1986, 136:1442-1445.
21. Bhatia SK, Tygrett LT, Grabstein KH, Waldschmidt IJ: The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med 1995, 181:1399-1409.
22. Semenzato G, Agostini C, Ometto L, et al.: CD8+ T lymphocytes in the lung of acquired immunodefiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995, 9:2308-2314.
23. Lanier LL, Recktenwald DJ: Multicolor immunofluorescence and flow cytometry. Methods: A Companion to Methods in Enzymology 1991:192-199.
24. Bean AGD, Godfrey DL, Ferlin WG, et al.: CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of α/β TCR+CD4-CD8- thymocytes. Int Immunol 1995, 2:213-221.
25. Budd RC, Van Houten N, Clements J, Mixter PF: Parallels in T lymphocyte development between lpr and normal mice. Semin Immunol 1994, 6:43-48.
26. Brooks EG, Wirt DP, Goldblum RM, et al.: Double-negative (CD4-CD8-) T cells with an α/βT cell receptor. J Immunol 1990, 144:4507-4512.